tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Evommune, Inc. (EVMN)
NYSE:EVMN
US Market
EVMN
Evommune, Inc.
RESEARCH TOOLSreports

Evommune, Inc. (EVMN) Stock News & Sentiment

Compare
42 Followers
Evommune: Buy Rating Driven by Upcoming Phase II Readouts and Broad Inflammatory Disease Pipeline Potential
Premium
Ratings
Evommune: Buy Rating Driven by Upcoming Phase II Readouts and Broad Inflammatory Disease Pipeline Potential
8d ago
EVMN
Evommune’s EVO756 Trial Targets High-Need Urticaria Market: What Investors Should Watch
Premium
Company Announcements
Evommune’s EVO756 Trial Targets High-Need Urticaria Market: What Investors Should Watch
10d ago
EVMN
3 ‘Strong Buy’ Stocks to Buy Now,12/30/2025, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Now,12/30/2025, According to Top Analysts
17d ago
VIR
EVMN
Evommune: Multiple 2026 Phase II Readouts and Novel Immunology Mechanisms Drive Compelling Buy-Rated Risk‑Reward
Premium
Ratings
Evommune: Multiple 2026 Phase II Readouts and Novel Immunology Mechanisms Drive Compelling Buy-Rated Risk‑Reward
18d ago
EVMN
Buy Rating for Evommune, Inc. Driven by EVO756’s Promising Phase II Trial Potential
Premium
Ratings
Buy Rating for Evommune, Inc. Driven by EVO756’s Promising Phase II Trial Potential
1M ago
EVMN
Evommune, Inc.: Promising Pipeline and Strategic Trials Drive Buy Rating
Premium
Ratings
Evommune, Inc.: Promising Pipeline and Strategic Trials Drive Buy Rating
1M ago
EVMN
Promising Outlook for Evommune’s EVO756: Buy Rating Backed by Strong Data and Market Potential
Premium
Ratings
Promising Outlook for Evommune’s EVO756: Buy Rating Backed by Strong Data and Market Potential
2M ago
EVMN
More EVMN News >

News Score - Last 7 Days

Neutral
EVMN
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.75 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is EVMN’s Media Buzz Sentiment?
2 articles about EVMN were published this week. In an average week, 1.75 articles are published.
    What is EVMN’s weekly average amount of articles?
    In an average week, 1.75 articles about EVMN are published.
      What is EVMN’s News Sentiment?
      50% of articles about EVMN were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        Showing the stocks with the most bullish news sentiment over the past week